💧

Understanding Hyperosmolar Hyperglycemic Non-Ketotic State

Apr 26, 2025

Lecture Notes: Hyperosmolar Hyperglycemic Non-Ketotic State (HHNS)

Overview

  • Diabetes mellitus is the 8th leading cause of death globally.
  • Chronic complications: kidney disease, cardiovascular disease.
  • Acute complications: Diabetic ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Non-Ketotic State (HHNS).
  • HHNS has a high mortality rate (8-20%).

Clinical Presentation of HHNS

  • Occurs in individuals with a prior diabetes diagnosis.
  • Symptoms develop over days to weeks:
    • Fatigue
    • Weight loss
    • Extreme thirst
    • Frequent urination
    • Signs of dehydration (e.g., tachycardia, hypotension, dry mucus membranes, decreased skin turgor).
    • Severe cases: confusion or altered mental status.

Pathophysiology of HHNS

  • Hyperglycemia: Due to insulin deficiency.
    • Type 1 diabetes: absolute deficiency.
    • Type 2 diabetes: relative deficiency (insulin production is present but inadequate response).
  • Insulin's role:
    • Pulls glucose from blood into cells for storage/energy.
    • In diabetes, glucose is not appropriately utilized, causing high blood sugar.

Metabolic Details

  • Hyperosmolarity:
    • Glucose is osmotically active, causing water to follow it.
    • High glucose in blood pulls water from cells to maintain concentration.
    • Kidneys can't reabsorb excess glucose during severe hyperglycemia, leading to glucose in urine.
    • Water follows glucose into urine, causing rapid fluid loss (osmotic diuresis).
    • Result: dehydration, increased solute concentration in blood.

Differentiation: HHNS vs. DKA

  • Non-Ketotic in HHNS:
    • Most HHNS patients have type 2 diabetes (pancreas produces insulin).
    • Insulin inhibits ketogenesis, preventing ketone (ketoacid) production.
    • In DKA (more common in type 1 diabetes), lack of insulin leads to ketone production, causing acidosis.

Treatment of HHNS

  • HHNS requires ICU treatment due to severity.
  • Major Treatments:
    1. Intravenous (IV) Insulin:
      • Corrects insulin deficit, lowers blood glucose.
      • Reduces osmotic diuresis and blood hyperosmolarity.
    2. Aggressive Rehydration:
      • IV fluids (e.g., normal saline) replenish lost fluids.
      • Alleviates dehydration signs (tachycardia, hypotension, altered mental status).

Conclusion

  • HHNS is a serious complication of type 2 diabetes.
  • Immediate medical evaluation is crucial for individuals with type 2 diabetes who become very ill.
  • Aggressive treatment with IV insulin and fluids is necessary to prevent fatal outcomes.